期刊文献+

抑郁症中枢神经递质及治疗研究进展 被引量:24

Advanced in search for central neurotransmitters and treatment involved in depression
暂未订购
导出
摘要 抑郁症的发病机制十分复杂,本文就抑郁症涉及的中枢神经递质进行综述,按照单胺类、氨基酸类、乙酰胆碱和神经肽类进行介绍,并探讨临床抑郁治疗目前遇到的挑战和处理办法及展望。 Clinical depression is viewed as a physical and psychic disease process,although a clear understanding of its etiopathology is still missing.This article introduced the development of central neurotransmitters involved in depression,containing monoamines,amino acids,acetylcholine and neuropeptides.Then discussed multiple unmet clinical needs and the strategies to treat these in depression.
作者 张文渊 李焕德 ZHANG Wen–yuan;LI Huan-de(Clinical Pharmaceutical ResearchInstitute,The Second Xiangya Hospi-tal,Central South University,Chang-sha 410011,China;School of Phar-maceutical Sciences,Central South Uni-versity,Changsha 410013,China)
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2010年第7期540-544,共5页 The Chinese Journal of Clinical Pharmacology
关键词 抑郁症 中枢神经递质 抑郁症治疗 depression central neurotransmitter depression treatment
  • 相关文献

参考文献31

  • 1Murphy GM,Kremer C,Rodrigues HE,et al.Pharmacogenetics of antidepressant medication intolerance[J].Am J Psychiatry,2003; 160:1830-1835.
  • 2Duman RS,Heninger GR,Nestler EJ.A molecular and cellular theory of depression[J].Arch Gen Psychiatry,1997; 54:597 -606.
  • 3Sanacora G,Zarate CA,Krystal JH,et al.Targeting the gluta-matergic system to develop novel,improved therapeutics for mood disorders[J].Nat Rev Drug Discov,2008;7:426 -437.
  • 4Ongur D,Drevets WC,Price JL.Glial reduction in the subgenual prefrontal cortex in mood disorders[J].Proc Natl Acad Sci USA,1998;95:13290-13295.
  • 5Sanacora G,Mason GF,Rothman DL,et al.Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy[J].Arch Gen Psychiatry,1999;56:1043-1047.
  • 6Sanacora G,Mason GF,Rothman DL,et al.Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors[J].Am J Psychiatry,2002;159:663-665.
  • 7Fatemi SH,Stary JM,Earle JA,et al.GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum[J].Schizophr Res,2005 ;72.109 -122.
  • 8Benes FM,Todtenkopf MS,Logiotatos P,et al.Glutamate decarboxylase (65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain[J].J Chem Neuroanat,2000;20:259-269.
  • 9Kugaya A,Sanacora G.Beyond monoamines:glutamatergic function in mood disorders[J].CNS Spectr,2005;10:808 -819.
  • 10刘惠芬,周文华,谢小虎,曹君利,顾钧,杨国栋.M受体对吗啡戒断大鼠脊髓和脑干NMDA受体基因表达及中脑导水管周围灰质中谷氨酸释放的调节[J].生理学报,2004,56(1):95-100. 被引量:14

二级参考文献5

  • 1周文华 Xie XH Liu HF Yang GD.The expression of nitric oxide synthase mRNA in spinal cord and brainstem during morphine dependence and withdrawal in rats[M].Chin Pharmacol Bull (中国药理学通报),2000.16:99-102.
  • 2曹君利 Liu HF Zhou WH Yang GD Zhang LC Zeng YM.Intrathecal injection of NOS antisense oligonucleotides inhibits the increase of NMDA1AR mRNA expression in the spinal cord and bralnstem of morphine-withdrawal rat[J]..
  • 3杨国栋 Zhou WH Zhang FQ Zhang YH Liu HF Zhu B Chen QJ.Experimental study of selective muscarinic receptor antagonists on attenuation of morphine tolerance and dependence in the rats[J].Natl Med J China (中华医学),.
  • 4周文华 Liu HF Gu J Xia XH Tang SE Yang GD.Neuronal nitric oxide synthase antisense oligodeoxynuleotide attenuates morphine withdrawal symptoms in rats[J].China Pharmacol Bull (中国药理学通报),2000,16(6):668-691.
  • 5罗建红.配体门控离子通道[A].魏尔清主编.药理学前沿-信号蛋白因子基因与现代药理.第1版[C].北京:科学出版社,1999.120-136.

共引文献13

同被引文献325

引证文献24

二级引证文献224

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部